TIDMODX

RNS Number : 3531G

Omega Diagnostics Group PLC

15 November 2022

15 November 2022

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Confirmation of Interim Results

Investor Presentation

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms it will announce its interim results for the six months to 30 September 2022 on 24 November 2022.

Investor presentation

Jag Grewal, Chief Executive Officer, and Chris Lea, Chief Financial Officer, will provide a live presentation relating to the Company's Interim Results via the Investor Meet Company platform on 24 November 2022 at 4:30pm GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics Group Plc via:

https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor

Investors who already follow Omega Diagnostics Group Plc on the Investor Meet Company platform will automatically be invited.

Contacts:

 
 Omega Diagnostics Group PLC                                           www.omegadx.com 
 Jag Grewal, Chief Executive Officer                                   via Walbrook PR 
 Chris Lea, Chief Financial Officer 
 
 
 finnCap Ltd                                                        Tel: 020 7220 0500 
 Geoff Nash/Edward Whiley/George Dollemore (Corporate 
  Finance) 
 Alice Lane/Charlotte Sutcliffe 
  (ECM) 
 
 
 Walbrook PR Limited                        Tel: 020 7933 8780 or omega@walbrookpr.com 
 Paul McManus                                                       Mob: 07980 541 893 
 Lianne Applegarth                                                  Mob: 07584 391 303 
 Sam Allen                                                          Mob: 07502 558 258

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition .

www.omegadx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAKFLFFLAFFA

(END) Dow Jones Newswires

November 15, 2022 02:00 ET (07:00 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Omega Diagnostics Charts.